title: Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.
authors.forename: Ozden
authors.initials: O
authors.lastname: Altundag
authors.forename: Kadri
authors.initials: K
authors.lastname: Altundag
authors.forename: Ozlem
authors.initials: O
authors.lastname: Gundeslioglu
authors.forename: Yavuz S
authors.initials: YS
authors.lastname: Silay
authors.forename: Yeliz
authors.initials: Y
authors.lastname: Ersoy
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D045604:Extracellular Fluid / Q000187:drug effects; D005260:Female; D006801:Humans; D020360:Neoadjuvant Therapy / Q000009:adverse effects*; D009360:Neoplastic Cells, Circulating; D017239:Paclitaxel / Q000008:administration & dosage / Q000009:adverse effects*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel